4 not yet recruiting, 2 active not recruiting, 2 recruiting, 2 unknown. 3 Not applicable, 2 Phase 1, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Active not recruiting 2, Completed 1 |
| Phase 1 | 2 | Not yet recruiting 1, Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
| Phase 4 | 1 | Enrolling by invitation 1 |
Follow Metabolic Dysfunction Associated Steatotic Liver Disease: new trials by email Literature Review of Metabolic Dysfunction Associated Steatotic Liver Disease trials Research Report on Metabolic Dysfunction Associated Steatotic Liver Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Human Models of Selective Insulin Resistance: Pancreatic Clamp Insulin human, Octreotide Acetate, Glucagon - Insulin Resistance, Hyperinsulinemia | Phase 1 | Not yet recruiting | Columbia University | 36 | 2027-01-01 | 2026-02-06 |
| Assessment of Circulating Leptin Levels in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease Serum Leptin Measurement - Metabolic Dysfunction Associated Steatotic Liver Disease | Not yet recruiting | Sohag University | 96 | 2026-10-15 | 2026-10-14 | |
| Tirzepatide's Effects on Epigenetic Aging and Metabolic Restoration in Virally Suppressed People With HIV Tirzepatide - Human Immunodeficiency Virus (HIV), Metabolic Dysfunction Associated Steatotic Liver Disease | Phase 4 | Enrolling by invitation | National Taiwan University Clinical Trial Center | 60 | 2026-06-25 | 2026-07-20 |
| Prognostic Model for MASLD Related Cirrhosis Lifestyle Guidance - Metabolic Dysfunction Associated Steatotic Liver Disease, Compensated Cirrhosis | Not yet recruiting | Beijing Friendship Hospital | 228 | 2025-08-13 | 2025-07-24 | |
| Aspirin for Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease Aspirin 81 mg Enteric Coated Tab - 1 tablet, Placebo - Metabolic Dysfunction Associated Steatotic Liver Disease | Phase 2 | Recruiting | Taichung Veterans General Hospital | 120 | 2025-05-05 | 2025-05-11 |
| Clinical Classification of MAFLD Based Liver Biopsy Metabolic Dysfunction Associated Steatotic Liver Disease, Metabolic Dysfunction-associated Steatohepatitis (MASH) | Not yet recruiting | Beijing Friendship Hospital | 2000 | 2025-02-08 | 2025-02-12 | |
| Feasibility of the Paso Program for Patients With Metabolic Dysfunction Associated Steatotic Liver Disease Paso Program - Metabolic Dysfunction Associated Steatotic Liver Disease, Overweight (BMI > 25) | Not applicable | Active not recruiting | Baylor College of Medicine | 50 | 2025-02-05 | 2026-03-24 |
| COmmencing Menopausal HOrmone Replacement Therapy and the Effect on Metabolic-dysfunction Associated Steatotic Liver Disease: a Pilot Mechanistic Study Menopausal hormone therapy - Menopause, Metabolic Dysfunction Associated Steatotic Liver Disease | Phase 1 | Recruiting | University of Oxford | 10 | 2025-01-01 | 2025-01-13 |
| Pattern of Cardiac Arrhythmia in Patients With MASLD Transient elastography - Cardiac Arrhythmia, Metabolic Dysfunction Associated Steatotic Liver Disease | Unknown | Sohag University | 100 | 2024-07-26 | 2024-08-07 | |
| Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Adults MASLD Patients (DELI_MASLD Study) Probiotic lysate (postbiotic and metabiotc), Placebo - Metabolic Dysfunction Associated Steatotic Liver Disease, Steatotic Liver Disease | Not applicable | Completed | Bogomolets National Medical University | 52 | 2024-05-01 | 2026-09-23 |
| Non-Invasive Diagnostic Tests for MASLD in Pediatric Population Velacur, MRI, Blood sample collection for biomarkers - Metabolic Dysfunction Associated Steatotic Liver Disease, Non-Alcoholic Fatty Liver Disease (NAFLD) | Not applicable | Active not recruiting | Emory University | 200 | 2024-01-18 | 2026-04-08 |
| Investigating Myosteatosis in Steatotic Liver Diseases Alcohol-related Liver Disease, Metabolic Dysfunction Associated Steatotic Liver Disease | Unknown | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 100 | 2020-06-22 | 2024-07-23 |
Non-alcoholic Fatty Liver Disease (3) · Obesity (3) · Diabetes Mellitus (2) · Fatty Liver (2) · Metabolic Syndrome (2) · Overweight (2) · Acquired Immunodeficiency Syndrome (1) · Arrhythmias, Cardiac (1) · Dyslipidemias (1) · Hyperinsulinism (1) · Insulin Resistance (1) · Platelet Glycoprotein IV Deficiency (1) · Prediabetic State (1) · Weight Loss (1)
Digestive System Diseases (4) · Liver Diseases (4) · Pathological Conditions, Signs and Symptoms (4) · Body Weight (3) · Glucose Metabolism Disorders (3) · Metabolic Diseases (3) · Nutrition Disorders (3) · Nutritional and Metabolic Diseases (3) · Overnutrition (3) · Signs and Symptoms (3) · Endocrine System Diseases (2) · Fatty Liver (2) · Hyperinsulinism (2) · Insulin Resistance (2) · Blood-Borne Infections (1)
Aspirin (1) · Electrocardiography (1) · Glucagon (1) · Glucose (1) · Hormone Replacement Therapy (1) · Human Growth Hormone (1) · Insulin (1) · Octreotide (1) · Tirzepatide (1)
Beijing Friendship Hospital (2) · Sohag University (2) · Baylor College of Medicine (1) · Bogomolets National Medical University (1) · Cliniques universitaires Saint-Luc- Université Catholique de Louvain (1) · Columbia University (1) · Emory University (1) · National Taiwan University Clinical Trial Center (1) · Taichung Veterans General Hospital (1) · University of Oxford (1)
United States (3) · China (2) · Taiwan (2) · Belgium (1) · Egypt (1) · Ukraine (1) · United Kingdom (1)
Hong You, PhD. / M.D. (1) · Joshua R Cook, MD, PhD (1) · Maya Balakrishnan (1) · Miriam Vos, MD (1) · Mohamed Ahmed Mostafa, Lecturer (1) · Nicolas Lanthier, MD, PhD (1) · Teng-Yu Lee, MD, MBA, PhD (1)
K12DK133995 (1), K23MD016955 (1), P30DK063608 (1)